.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Moodys
Cantor Fitzgerald
Deloitte
Chubb
Citi
Harvard Business School
Chinese Patent Office
US Army

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,778,999

« Back to Dashboard

Which drugs does patent 8,778,999 protect, and when does it expire?


Patent 8,778,999 protects BROMSITE and is included in one NDA.

This patent has four patent family members in six countries.

Summary for Patent: 8,778,999

Title:Non-steroidal anti-inflammatory ophthalmic compositions
Abstract: The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.
Inventor(s): Hosseini; Kamran (Los Altos, CA), Bowman; Lyle (Pleasanton, CA), Si; Erwin C. (Alameda, CA), Pham; Stephen (Sacramento, CA)
Assignee: Insite Vision Incorporated (Alameda, CA)
Application Number:12/398,657
Patent Claim Types:
see list of patent claims
Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sun Pharma Global
BROMSITE
bromfenac sodium
SOLUTION/DROPS;OPHTHALMIC206911-001Apr 8, 2016RXYesYes► Subscribe► SubscribeY TREATMENT OF POSTOPERATIVE INFLAMMATION AND PREVENTION OF OCULAR PAIN IN PATIENTS UNDERGOING CATARACT SURGERY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,778,999

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark2403493► Subscribe
European Patent Office2403493► Subscribe
Spain2586064► Subscribe
Portugal2403493► Subscribe
Canada2753947► Subscribe
World Intellectual Property Organization (WIPO)2010102192► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Fuji
Moodys
Colorcon
Teva
Cantor Fitzgerald
Harvard Business School
QuintilesIMS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot